These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8299025)

  • 1. The effect of tissue plasminogen activator (t-PA) on cerebral vasospasm in canine subarachnoid hemorrhage.
    Chung WY; Lee LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Nov; 52(5):298-306. PubMed ID: 8299025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
    Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW
    Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
    Seifert V; Eisert WG; Stolke D; Goetz C
    Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
    Findlay JM; Weir BK; Steinke D; Tanabe T; Gordon P; Grace M
    J Neurosurg; 1988 Nov; 69(5):723-35. PubMed ID: 3141595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
    No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kanamaru K; Grace M; Baughman R
    Neurosurgery; 1990 Feb; 26(2):201-6. PubMed ID: 2106630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M; Saito N; Hoya K; Todo T
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
    Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM
    J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Ohman J; Servo A; Heiskanen O
    J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovations in aneurysmal subarachnoid hemorrhage: intracisternal t-PA for the prevention of vasospasm.
    Bell TE; Kongable GL
    J Neurosci Nurs; 1996 Apr; 28(2):107-13. PubMed ID: 8718759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy with tissue plasminogen activator for prevention of vasospasm in experimental subarachnoid hemorrhage: its efficacy and problems.
    Asada M; Kong J; Nakamura M; Tamaki N
    Neurol Res; 1996 Aug; 18(4):342-4. PubMed ID: 8875453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms.
    Górski R; Zabek M; Jarmuzek P
    Neurol Neurochir Pol; 2000; 34(6 Suppl):41-7. PubMed ID: 11452854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm.
    Findlay JM; Weir BK; Gordon P; Grace M; Baughman R
    Neurosurgery; 1989 Apr; 24(4):491-8. PubMed ID: 2496328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant streptokinase on the development of chronic cerebral vasospasm after subarachnoid hemorrhage in a swine model.
    Xu H; Chen X; Qin Z; Gu Y; Zhou P
    Acta Neurochir (Wien); 2011 Jun; 153(6):1333-8; discussion 1338. PubMed ID: 21311917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.